KPNA7, a nuclear transport receptor, promotes malignant properties of pancreatic cancer cells in vitro

Experimental Cell Research

Volumn 322, Issue 1, 2014, Pages 159-167

  Laurila, Eeva ^a,b   Vuorinen, Elisa ^a,b   Savinainen, Kimmo ^a   Rauhala, Hanna ^a   Kallioniemi, Anne ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b FIMLAB LABORATORIES   (Finland)

Author keywords

Autophagy; Cell cycle; KPNA7; Nuclear transport; P21; Pancreatic cancer

Indexed keywords

CELL NUCLEUS RECEPTOR; KARYOPHERIN ALPHA 7; PROTEIN P21; UNCLASSIFIED DRUG;

ADULT; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CELL GROWTH; COLONY FORMATION; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MESSENGER RNA SYNTHESIS; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA SYNTHESIS;

AUTOPHAGY; CELL CYCLE; KPNA7; NUCLEAR TRANSPORT; P21; PANCREATIC CANCER;

ACTIVE TRANSPORT, CELL NUCLEUS; ADULT; ALPHA KARYOPHERINS; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PANCREATIC NEOPLASMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 84893729154     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.11.014     Document Type: Article

References (49)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J. Clin. 2012, 62:10-29.
2. Bardeesy N., DePinho R.A. Pancreatic cancer biology and genetics. Nat. Rev. Cancer 2002, 2:897-909.
3. Wang Z., Li Y., Ahmad A., Banerjee S., Azmi A.S., et al. Pancreatic cancer: understanding and overcoming chemoresistance. Nat. Rev. Gastroenterol. Hepatol. 2011, 8:27-33.
4. Goldfarb D.S., Corbett A.H., Mason D.A., Harreman M.T., Adam S.A. Importin alpha: a multipurpose nuclear-transport receptor. Trends Cell Biol. 2004, 14:505-514.
5. Kelley J.B., Talley A.M., Spencer A., Gioeli D., Paschal B.M. Karyopherin alpha7 (KPNA7), a divergent member of the importin alpha family of nuclear import receptors. BMC Cell Biol. 2010, 11:63.
6. Pemberton L.F., Paschal B.M. Mechanisms of receptor-mediated nuclear import and nuclear export. Traffic 2005, 6:187-198.
7. Marfori M., Mynott A., Ellis J.J., Mehdi A.M., Saunders N.F., et al. Molecular basis for specificity of nuclear import and prediction of nuclear localization. Biochim. Biophys. Acta 2011, 1813:1562-1577.
8. Mosammaparast N., Pemberton L.F. Karyopherins: from nuclear-transport mediators to nuclear-function regulators. Trends Cell Biol. 2004, 14:547-556.
9. Kotera I., Sekimoto T., Miyamoto Y., Saiwaki T., Nagoshi E., Sakagami H., et al. Importin alpha transports CaMKIV to the nucleus without utilizing importin beta. EMBO J. 2005, 24:942-951.
10. Tejomurtula J., Lee K.B., Tripurani S.K., Smith G.W., Yao J. Role of importin alpha8, a new member of the importin alpha family of nuclear transport proteins, in early embryonic development in cattle. Biol. Reprod. 2009, 81:333-342.
11. Hu J., Wang F., Yuan Y., Zhu X., Wang Y., et al. Novel importin-alpha family member KPNA7 is required for normal fertility and fecundity in the mouse. J. Biol. Chem. 2010, 285:33113-33122.
12. Wang X., Park K.E., Koser S., Liu S., Magnani L., et al. KPNA7, an oocyte- and embryo-specific karyopherin alpha subtype, is required for porcine embryo development. Reprod. Fertil. Dev. 2012, 24:382-391.
13. Park K.E., Inerowicz H.D., Wang X., Li Y., Koser S., et al. Identification of karyopherin alpha1 and alpha7 interacting proteins in porcine tissue. PLoS ONE 2012, 7:e38990.
14. Laurila E., Savinainen K., Kuuselo R., Karhu R., Kallioniemi A. Characterization of the 7q21-q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer. Genes Chromosomes Cancer 2009, 48:330-339.
15. Faustino R.S., Nelson T.J., Terzic A., Perez-Terzic C. Nuclear transport: target for therapy. Clin. Pharmacol. Ther. 2007, 81:880-886.
16. Moll U.M., Riou G., Levine A.J. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc. Natl. Acad. Sci. USA 1992, 89:7262-7266.
17. Kim I.S., Kim D.H., Han S.M., Chin M.U., Nam H.J., et al. Truncated form of importin alpha identified in breast cancer cell inhibits nuclear import of p53. J. Biol. Chem. 2000, 275:23139-23145.
18. Dahl E., Kristiansen G., Gottlob K., Klaman I., Ebner E., et al. Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer. Clin. Cancer Res. 2006, 12:3950-3960.
19. Gluz O., Wild P., Meiler R., Diallo-Danebrock R., Ting E., et al. Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity. Int. J. Cancer 2008, 123:1433-1438.
20. Sakai M., Sohda M., Miyazaki T., Suzuki S., Sano A., et al. Significance of karyopherin-{alpha} 2 (KPNA2) expression in esophageal squamous cell carcinoma. Anticancer Res. 2010, 30:851-856.
21. Zheng M., Tang L., Huang L., Ding H., Liao W.T., et al. Overexpression of karyopherin-2 in epithelial ovarian cancer and correlation with poor prognosis. Obstet. Gynecol. 2010, 116:884-891.
22. Jensen J.B., Munksgaard P.P., Sorensen C.M., Fristrup N., Birkenkamp-Demtroder K., et al. High expression of karyopherin-alpha2 defines poor prognosis in non-muscle-invasive bladder cancer and in patients with invasive bladder cancer undergoing radical cystectomy. Eur. Urol. 2011, 59:841-848.
23. Mortezavi A., Hermanns T., Seifert H.H., Baumgartner M.K., Provenzano M., et al. KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clin. Cancer Res. 2011, 17:1111-1121.
24. Wang C.I., Wang C.L., Wang C.W., Chen C.D., Wu C.C., et al. Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome. Int. J. Cancer 2011, 128:2364-2372.
25. Altan B., Yokobori T., Mochiki E., Ohno T., Ogata K., Ogawa A., et al. Nuclear karyopherin-alpha2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer. Carcinogenesis 2013, 34:2314-2321.
26. Gousias K., Becker A.J., Simon M., Niehusmann P. Nuclear karyopherin a2: a novel biomarker for infiltrative astrocytomas. J. Neurooncol. 2012, 109:545-553.
27. Balazs M., Adam Z., Treszl A., Begany A., Hunyadi J., et al. Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization. Cytometry 2001, 46:222-232.
28. Riegman P.H., Vissers K.J., Alers J.C., Geelen E., Hop W.C., et al. Genomic alterations in malignant transformation of barrett's esophagus. Cancer Res. 2001, 61:3164-3170.
29. Morohara K., Nakao K., Tajima Y., Nishino N., Yamazaki K., et al. Analysis by comparative genomic hybridization of gastric cancer with peritoneal dissemination and/or positive peritoneal cytology. Cancer Genet. Cytogenet. 2005, 161:57-62.
30. Sy S.M., Wong N., Lai P.B., To K.F., Johnson P.J. Regional over-representations on chromosomes 1q, 3q and 7q in the progression of hepatitis B virus-related hepatocellular carcinoma. Mod. Pathol. 2005, 18:686-692.
31. Paciorkowski A.R., Weisenberg J., Kelley J.B., Spencer A., Tuttle E., et al. Autosomal recessive mutations in nuclear transport factor KPNA7 are associated with infantile spasms and cerebellar malformation. Eur. J. Hum. Genet. 2013, (Epub ahead of print), 10.1038/ejhg.2013.196.
32. Miller S.J., Lavker R.M., Sun T.T. Interpreting epithelial cancer biology in the context of stem cells: tumor properties and therapeutic implications. Biochim. Biophys. Acta 2005, 1756:25-52.
33. Kelleher F.C., Fennelly D., Rafferty M. Common critical pathways in embryogenesis and cancer. Acta Oncol. 2006, 45:375-388.
34. Ben-Porath I., Thomson M.W., Carey V.J., Ge R., Bell G.W., et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 2008, 40:499-507.
35. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
36. Malumbres M., Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer 2001, 1:222-231.
37. Abbas T., Dutta A. P21 in cancer: intricate networks and multiple activities. Nat. Rev. Cancer 2009, 9:400-414.
38. Malumbres M., Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 2009, 9:153-166.
39. Gruss O.J., Carazo-Salas R.E., Schatz C.A., Guarguaglini G., Kast J., et al. Ran induces spindle assembly by reversing the inhibitory effect of importin alpha on TPX2 activity. Cell 2001, 104:83-93.
40. Tsai M.Y., Wiese C., Cao K., Martin O., Donovan P., et al. A ran signalling pathway mediated by the mitotic kinase aurora A in spindle assembly. Nat. Cell Biol. 2003, 5:242-248.
41. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
42. Kondo Y., Kanzawa T., Sawaya R., Kondo S. The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer 2005, 5:726-734.
43. Mathew R., Karantza-Wadsworth V., White E. Role of autophagy in cancer. Nat. Rev. Cancer 2007, 7:961-967.
44. Li X.L., Jia L.L., Shi M.M., Li X., Li Z.H., et al. Downregulation of KPNA2 in non-small-cell lung cancer is associated with Oct4 expression. J. Transl. Med. 2013, 11:232.
45. Noetzel E., Rose M., Bornemann J., Gajewski M., Knuchel R., et al. Nuclear transport receptor karyopherin-alpha2 promotes malignant breast cancer phenotypes in vitro. Oncogene 2012, 31:2101-2114.
46. Yuan B., Latek R., Hossbach M., Tuschl T., Lewitter F. siRNA selection server: an automated siRNA oligonucleotide prediction server. Nucleic Acids Res. 2004, 32:W130-4.
47. Kuuselo R., Savinainen K., Azorsa D.O., Basu G.D., Karhu R., et al. Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification. Cancer Res. 2007, 67:1943-1949.
48. Abramoff M.D., Magelhaes P.J., Ram S.J. Image processing with Image. J. Biophotonics Int. 2004, 11:36-42.
49. Kallio H., Tolvanen M., Janis J., Pan P.W., Laurila E., et al. Characterization of non-specific cytotoxic cell receptor protein 1: a new member of the lectin-type subfamily of F-box proteins. PLoS ONE 2011, 6:e27152.